US › Healthcare

Talphera Inc. (TLPH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.17-1.68%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-4.3M

EPS

$-0.06

EPS estimate

$-0.07

EPS came in at -0.06 against a street estimate of -0.07 — a beat of 14.3%.

Key statistics

Market cap

$64.4M

Forward P/E

1.0

P/B

4.47

Book value

$0.37

EPS (TTM)

$-0.23

52-week high

$1.57

52-week low

$0.69

50-day MA

$1.28

200-day MA

$1.02

Beta

0.69

Analyst view

Analysts rate Talphera Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.17.

Shareholding

Insiders

21.41%

Institutions

46.03%

Largest institutional holders

Fund	Stake
AIGH Capital Management, LLC	8.87%
Rock Springs Capital Management LP	6.91%
Nantahala Capital Management, LLC	6.73%
Rosalind Advisors, Inc.	6.46%
Bleichroeder LP	2.52%
CANTOR FITZGERALD, L. P.	1.71%
Caption Management, LLC	1.08%
Almitas Capital LLC	0.90%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Talphera Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.